electroCore vs Stereotaxis
ECOR and STXS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ECOR and STXS compare
Stereotaxis is the larger company, worth 1.8 times as much as electroCore ($84.5M against $47.3M).
electroCore grew revenue faster over the last twelve months (27.3% versus −5.5% for Stereotaxis).
electroCore keeps more of each dollar of sales as profit, with a net margin of −33.5% compared with −74.2% at Stereotaxis.
Stereotaxis scores higher on the StockData Score (8 against 7 for electroCore), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ECOR | STXS |
|---|---|---|
| Size and price | ||
| Market cap | $47.3M | $84.5M |
| Share price | $5.25 | $0.843 |
| Change, 1 year | −13.4% | −65.3% |
| Change, 5 years | −53.8% | −86.9% |
| Beta (5Y) | 1.09 | 1.23 |
| Employees | 83 | 131 |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.2× (better) | 2.8× |
| P/B | – | 6.9× |
| FCF yield | −23.0% | −18.3% (better) |
| Fair value | – | $1.07 |
| Margin of safety | – | 21.5% |
| Growth | ||
| Revenue growth (TTM) | 27.3% (better) | −5.5% |
| Revenue growth, 5Y average | 55.7% (better) | 4.0% |
| Profitability | ||
| Gross margin | 87.7% (better) | 55.6% |
| Operating margin | −33.1% (better) | −75.7% |
| Net margin | −33.5% (better) | −74.2% |
| FCF margin | −28.7% (better) | −51.6% |
| Return on equity | – | −326% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −960.7× | – |
| Current ratio | 1.34 | 1.42 (better) |
| Altman Z-score | −14.80 | −14.19 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −25.1% |
| Shareholder yield | 0.00% (better) | −25.1% |
| Ownership | ||
| Held by institutions | 11.4% | 43.0% |
| Held by insiders | 16.6% | 20.3% |
| Insider net buying, 12 months | −$721K | $0 (better) |
| Short interest, % of float | 4.8% | 7.0% |
Go deeper
- ECOR stock overview
- ECOR income statement
- ECOR valuation and score
- STXS stock overview
- STXS income statement
- STXS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.